Harvard Health Blog

Update on the SPRINT trial: Preliminary results pan out

Posted November 09, 2015, 2:10 pm Deepak Bhatt, M.D., M.P.H., Editor in Chief, Harvard Heart Letter In a previous blog, I reported on the preliminary results from SPRINT, a clinical trial that examined whether a systolic blood pressure target of 120 mm Hg or less would be better than a target of 140 mm Hg in patients with hypertension (high blood pressure). The National Heart, Lung, and Blood Institute of the National Institutes…

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In